Venture Capital

Updated:

Théa Open Innovation

Théa Open Innovation is a venture capital firm founded in 2019, headquartered in Montreal, Canada, with roots in Clermont-Ferrand, France. The firm focuses on...

Théa Open Innovation

Théa Open Innovation is a venture capital firm founded in 2019, headquartered in Montreal, Canada, with roots in Clermont-Ferrand, France. The firm focuses on the development of treatments for eye diseases within the pharmaceutical and healthcare sectors. Its investment strategy centers on identifying and assessing partnerships with start-ups, universities, and research teams to explore solutions for therapeutic advancements. While its primary focus is on eye health, Théa Open Innovation may also engage with various sectors that contribute to healthcare innovation. The collaborative entity operates through its website, theaopeninnovation.com, as it seeks out promising therapeutic advancements in ophthalmology and broader healthcare innovation. No specific fund sizes, portfolio companies, or AUM figures have been disclosed.

General information

Firm type

Venture Capital

Location

Region

North America

Country

Canada

City

Montreal

Corporate office

Montreal, Canada

Sector focus

Venture CapitalCanada

Frequently asked questions

What is Théa Open Innovation's primary investment focus?

Théa Open Innovation primarily focuses on the development of treatments for eye diseases within the pharmaceutical and healthcare sectors, while also engaging with various sectors contributing to broader healthcare innovation.

What types of partners does Théa Open Innovation work with?

The firm identifies and assesses partnerships with start-ups, universities, and research teams to explore therapeutic advancements in eye health and related healthcare areas.

When was Théa Open Innovation founded and where is it headquartered?

Théa Open Innovation was founded in 2019 and is headquartered in Montreal, Canada, with origins in Clermont-Ferrand, France.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Montreal Venture Capital profiles